NIHON DEMPA KOGYO (6779) FY2026 Q3 Earnings Report

Quick View

Executive Summary

The Company posted higher revenue but lower earnings, as revenue remained broadly in line with the previous year while gross margin and operating margin declined. Revenue was ¥39.88B (+0.5% YoY), Operating Income was ¥2.19B (-40.0%), and Net Income was ¥1.09B (-45.5%). The primary factors behind the decline in earnings were the 235bp decrease in gross margin to 28.4% and the increase in the SG&A expense ratio to 18.4%. Progress toward the full-year forecast was 74.7% for revenue, compared with 68.4% for Operating Income and 64.1% for Net Income, making the recovery of profitability in Q4 a key focus.

Factors Affecting Performance

【Revenue】Revenue was ¥39.88B, remaining almost flat at +0.5% YoY. Progress toward the full-year forecast of ¥53.40B was 74.7%, broadly in line with the standard progress rate for the cumulative Q3 period.

【Profit and Loss】Operating Income was ¥2.19B (-40.0%), Profit Before Tax, corresponding to the ordinary-income stage, was ¥1.52B (-46.2%), and Net Income was ¥1.09B (-45.5%), with the decline in earnings significantly exceeding the growth in revenue. Gross margin decreased from 30.7% to 28.4%, with higher costs serving as the primary pressure factor. SG&A expenses were ¥7.35B, up 5.0% YoY and exceeding the revenue growth rate. Within this amount, R&D expenses were ¥1.98B (+27.3%), and increased technology investment contributed to the rise in the SG&A expense ratio (17.6%→18.4%). Financial expenses of ¥0.59B exceeded financial income of ¥0.07B, resulting in a decline from Operating Income to Profit Before Tax. Overall, the Company posted higher revenue but lower earnings.

Key Financial Indicators

【Profitability】Operating margin declined to 5.5% (9.2% in the previous year), while Net Income margin decreased to 2.7% (5.0% in the previous year). Annualized ROE was 4.7% and annualized ROIC was only 3.7%. The DuPont decomposition explains ROE of 4.7% as Net Income margin of 2.7% × total asset turnover of 0.73x × financial leverage of 2.36x, indicating that low profitability was the primary factor depressing ROE.【Cash Flow Quality】Operating Cash Flow (OCF) of ¥2.896B was 2.66 times Net Income of ¥1.089B, indicating solid cash backing for earnings; however, inventory increased by ¥1.682B, placing pressure on working capital. Annualized DSO was 93 days, DIO was 120 days, and CCC was 125 days, all above benchmark levels for collections and inventory turnover.【Investment Efficiency】The Company was unable to cover capital expenditures of ¥3.277B and intangible asset acquisitions of ¥0.888B, resulting in company-calculated free cash flow of negative ¥2.630B. R&D expenses were 5.0% of revenue, reflecting a higher level of investment than in the previous year.【Financial Soundness】The equity ratio was 42.4% (40.8% in the previous year), and the current ratio was 333.5%, indicating strong short-term payment capacity. However, interest coverage, measured by EBIT/financial expenses, remained at 3.7x.

Cash Flow Analysis

OCF was ¥2.896B, exceeding Net Income of ¥1.089B, indicating progress in the conversion of earnings into cash. However, the ¥1.682B increase in inventory was a drag, partly offset by a ¥1.455B increase in accounts payable. Investing Cash Flow was an outflow of ¥5.526B, primarily attributable to capital expenditures of ¥3.277B and intangible asset acquisitions of ¥0.888B. As a result, free cash flow, calculated as the sum of OCF and Investing Cash Flow, was negative ¥2.630B, indicating that investment expenditures were not covered by internally generated funds. Financing Cash Flow was an outflow of ¥2.169B, including dividend payments of ¥0.662B, share repurchases of ¥0.044B, and debt repayments. Cash and cash equivalents were ¥11.481B, down from ¥15.881B in the previous year, indicating that excess investment and continued shareholder returns are placing pressure on cash reserves.

Earnings Quality

The decline from Operating Income of ¥2.19B to Profit Before Tax of ¥1.52B was primarily attributable to financial expenses of ¥0.589B exceeding financial income of ¥0.070B and a negative ¥0.152B in equity-method investment gains and losses; both are recurring items. OCF of ¥2.896B was 2.66 times Net Income of ¥1.089B, and the accrual ratio was negative, indicating good earnings quality from the perspective of cash backing. However, it should be noted that changes in working capital had a certain impact on OCF, with increases in inventory and accounts payable partially offsetting each other. Comprehensive income was ¥2.44B, exceeding Net Income of ¥1.09B, with other comprehensive income (foreign currency translation adjustments, etc.) making a positive contribution. This divergence was mainly attributable to foreign currency translation adjustments and should be distinguished from the underlying earnings power of the business.

Earnings Forecasts and Guidance

The full-year forecasts are revenue of ¥53.40B (+0.6% YoY), Operating Income of ¥3.20B (-30.8%), and Net Income of ¥1.70B (-5.2%). While cumulative Q3 progress was 74.7% for revenue, a standard level, progress was 68.4% for Operating Income and 64.1% for Net Income, both below the standard progress benchmark of approximately 75%. To achieve the full-year plan, approximately ¥1.01B in Operating Income will be required in Q4 alone, corresponding to an Operating margin of approximately 7.5% in Q4, above the 5.5% recorded for cumulative Q3. Improvement in gross margin and the SG&A expense ratio is a prerequisite for achieving the plan.

Shareholder Returns

The Q2 dividend was ¥15.00 per share, while the Company’s full-year forecast for annual dividends is ¥30.00 per share. The payout ratio based on cumulative Q3 Net Income of ¥1.089B was 31.9%, while the forecast payout ratio based on forecast full-year Net Income of ¥1.70B and forecast annual dividends of ¥30.00 per share was approximately 40.7%. Including share repurchases of ¥0.044B, the total return ratio based on cumulative Q3 Net Income was approximately 64.8%. As company-calculated free cash flow was negative ¥2.630B, dividends and share repurchases have primarily been conducted within the scope of cash on hand and OCF. The balance between shareholder returns and investment expenditures will determine the sustainability of future shareholder returns.

Risk Factors

1. Deterioration in working capital efficiency: Annualized DIO was 120 days, DSO was 93 days, and CCC was 125 days, all indicating extended periods. Inventory increased by ¥1.682B YoY, raising concerns about the risk of inventory valuation losses and funds becoming tied up during fluctuations in supply and demand.

2. Declining profitability and interest burden: As gross margin declined by 235bp and Operating margin declined by 371bp, financial expenses of ¥0.589B exceeded financial income of ¥0.070B, leaving interest coverage at 3.7x. Annualized ROIC was low at 3.7% relative to the cost of capital, and delays in restoring profitability could increase the relative burden of financial costs.

3. Investment burden and negative free cash flow: Capital expenditures of ¥3.277B and intangible asset acquisitions of ¥0.888B resulted in company-calculated free cash flow of negative ¥2.630B. If investment continues, the Company may face a further decline in cash on hand (¥11.481B, compared with ¥15.881B in the previous year) and greater reliance on external financing.

Industry Benchmark (For Reference; Company Analysis)

Industry Benchmark (manufacturing)

Profitability and Returns

The Company’s profitability is below the industry median, with both Operating margin and Net Income margin ranking in the lower tier of the industry.

Growth and Capital Efficiency

Revenue growth is also below the industry median, placing the Company at a relatively low level within the industry in terms of growth.

※Source: Compiled by the Company

Key Takeaways from the Earnings Results

1. While revenue was almost flat, Operating Income declined by 40.0%, making the normalization of gross margin and the SG&A expense ratio, rather than revenue growth, the central issue in the earnings results. R&D expenses increased by 27.3% YoY, reflecting additional investment, but this has not yet translated into improved margins.

2. OCF was 2.66 times Net Income, confirming solid cash backing for earnings. However, the increase in inventory, annualized DIO of 120 days, and CCC of 125 days indicate working capital accumulation. Trends in inventory and accounts receivable management are therefore structural points to monitor, as they will influence future cash generation capacity.

3. Progress toward the full-year Operating Income forecast was 68.4%, below the standard progress level, and the Operating margin required in Q4 will be approximately 200bp higher than the cumulative Q3 level. The annual dividend forecast of ¥30.00 per share is at least unchanged from the previous year, and the forecast payout ratio of approximately 40.7% is manageable based on earnings. However, the allocation of funds while free cash flow remains negative will be a key monitoring point.

Theoretical Share Price (Reference Value)

Sensitivity: ¥1,168–¥1,235 at ±1% for the cost of equity, and ¥1,197–¥1,204 at ±0.1 for ω.

Notes:

• Net Income is significantly compressed relative to Operating Income due to tax expenses, acquisition-related costs, non-controlling interests, and other factors (Net Income ÷ Operating Income 53%). This value reflects that compression at face value; if these factors are temporary, the normalized value may be higher.
• As forecast ROE is below the cost of equity, the theoretical value is below book value per share.
• Net assets as of the quarter-end are used, creating a timing difference from the full-year forecast.

(Calculation model: Residual income model (Ohlson-type, explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated using only publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee future share prices.)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting a professional as necessary.

---End of Report---